formed a broad business tieup with China's largest drug distributor, Sinopharm Group Co., to enter the burgeoning Chinese pharmaceutical market. In their first move, the major trading house and Japan's largest drug wholesaler will invest ¥2.8 billion...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Mitsubishi, Medipal join Sinopharm
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account